New innovation for recombinant antibodies that can help improve bioanalytical assays

In this interview Paul Royle (Technical Sales Manager, Bio-Rad Laboratories, UK) discusses the use of HuCAL® technology, which is a method of generating recombinant monoclonal antibodies using a synthetic antibody library and phage display. He explains how Bio-Rad has recently introduced SpyTag-SpyCatcher technology into the process, which enables site-specific antibody conjugation and rapid assembly of different antibody formats, and how this innovation can benefit bioanalysts.

Questions include:

1. What is HuCAL® technology?

2. Tell us about Bio-Rad’s innovation for recombinant antibodies

3. How is SpyTag technology of benefit to bioanalysts?

4. What do you see as the future developments in this area?

Click here to learn more about Bio-Rad

You may also be interested in…

Generating custom antibodies for bioanalytical research: an interview with Ulrich Mayer
In this interview Ulrich Mayer, Technical Sales Specialist (Bio-Rad Laboratories, CA, USA) discusses Bio-Rad’s custom recombinant antibody generation capabilities. Mayer explains why global biopharmaceutical companies and CROs choose Bio-Rad for the generation of custom antibodies targeting different types of large molecule drugs and CAR-T cell therapies. Mayer also describes the technology behind Bio-Rad’s custom antibody service, as well as commenting on what the future may hold for the partnership between Bio-Rad and bioanalytical scientists.

In the Zone: CAR-T cells
In this feature, we will investigate some of the trials and tribulations associated with researching and developing CAR-T cell therapies. We will also be looking at what the future may hold for the treatment and what benefits we may expect to see from furthering the development of immunotherapies.